BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32310030)

  • 1. Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT.
    Diala I; Shiohama Y; Fujita T; Kotake Y; Demonacos C; Krstic-Demonacos M; Leva GD; Fujii M
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):407-425. PubMed ID: 32310030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
    Folini M; Brambilla C; Villa R; Gandellini P; Vignati S; Paduano F; Daidone MG; Zaffaroni N
    Eur J Cancer; 2005 Mar; 41(4):624-34. PubMed ID: 15737568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
    Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
    Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
    de Souza Nascimento P; Alves G; Fiedler W
    Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
    Kurvinen K; Syrjänen S; Johansson B
    Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity.
    Natarajan S; Chen Z; Wancewicz EV; Monia BP; Corey DR
    Oligonucleotides; 2004; 14(4):263-73. PubMed ID: 15665594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analyses in bladder cancer cells: inhibition of hTERT expression down-regulates EGFR.
    Kraemer K; Schmidt U; Fuessel S; Herr A; Wirth MP; Meye A
    Int J Cancer; 2006 Sep; 119(6):1276-84. PubMed ID: 16615118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
    Nowak T; Januszkiewicz D; Zawada M; Pernak M; Lewandowski K; Rembowska J; Nowicka K; Mankowski P; Nowak J
    Oncol Rep; 2006 Aug; 16(2):301-5. PubMed ID: 16820907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
    Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
    Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA-mediated inhibition of hTERC enhances radiosensitivity of cervical cancer.
    Chen M; Xing LN
    Asian Pac J Cancer Prev; 2012; 13(12):5975-9. PubMed ID: 23464388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly sensitive inhibition of hTERT mRNA expression and telomerase activity by DNA-signal-peptide conjugates.
    Kubo T; Bakalova R; Zhelev Z; Ohba H; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2005; (49):337-8. PubMed ID: 17150771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
    Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N
    Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation.
    Guilleret I; Yan P; Guillou L; Braunschweig R; Coindre JM; Benhattar J
    Carcinogenesis; 2002 Dec; 23(12):2025-30. PubMed ID: 12507925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
    Goldkorn A; Blackburn EH
    Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic expression of human telomerase RNA component results in increased telomerase activity and elongated telomeres in bovine blastocysts.
    Garrels W; Kues WB; Herrmann D; Holler S; Baulain U; Niemann H
    Biol Reprod; 2012 Oct; 87(4):95. PubMed ID: 22855562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
    Rao Y; Xiong W; Liu H; Jia C; Zhang H; Cui Z; Zhang Y; Cui J
    Breast Cancer; 2016 Mar; 23(2):216-23. PubMed ID: 25098685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
    Gao XD; Chen YR
    Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.